Methods. A total of 173 pneumococcal invasive isolates were obtained during the period between 1991 and 2011. Serotypes were determined using the Quellung reaction, along with additional sequencing for capsular genes. Sequencing and allele typing for ply and phtD genes were performed using known or newly designed primers. Phylogenetic analysis was performed and antigenicity was compared for each allele type of the ply and phtD genes.
Background. The currently available vaccines for Streptococcus pneumoniae have limited serotype coverage. A protein-based universal vaccine could be a feasible and preferable alternative to broaden the protection provided by the vaccine. Pneumolysin (Ply) and pneumococcal histidine triad protein D (PhtD) are considered to be nextgeneration protein vaccine candidates. We aimed to analyze the genetic diversity of Ply and PhtD, and to evaluate their antigenic homogeneity.
Methods. A total of 173 pneumococcal invasive isolates were obtained during the period between 1991 and 2011. Serotypes were determined using the Quellung reaction, along with additional sequencing for capsular genes. Sequencing and allele typing for ply and phtD genes were performed using known or newly designed primers. Phylogenetic analysis was performed and antigenicity was compared for each allele type of the ply and phtD genes.
Results. A total of 27 serotypes were identified, with 19A (n = 30, 17.3%) and 23F (n = 24, 13.9%), being most common. In the ply gene, allele 1 (n = 64, 37.0%), 2 (n = 87, 50.3%), 3 (n = 4, 2.3%), 9 (n = 14, 8.1%), 10 (n = 1, 0.6%), and the newly assigned alleles 19 (n = 2, 1.2%) and 20 (n = 1, 0.6%) were identified. Analysis of the phtD gene with respect to nucleotide size revealed 13 allele types. Allele 5 (n = 127, 73.4%) was most common, followed by allele 9 (n = 14, 8.1%), 2 (n = 8, 4.6%), and 3 (n = 5, 2.9%). The sequence and antigenicity of the ply and phtD alleles displayed extensive homogeneity.
Conclusion. The genetic and antigenic diversity of Ply and PhtD was very limited. As candidates for the universal protein vaccine, the Ply and PhtD may have potential to broaden the coverage provided by the vaccine.
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